Ultima Genomics is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Ultima Genomics is a startup founded in 2017 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Ultima Genomics develops a high-throughput, low-cost sequencing platform designed to enable widespread genomic analysis. Their technology aims to significantly reduce the cost of whole human genome sequencing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.